[Current developments in antimycotic therapy in gynecology and obstetrics].
Laufer
B
B
Universitäts-Frauenklinik Frankfurt/Main.
Bender
H G
HG
D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D015725:Fluconazole / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D007231:Infant, Newborn; D017964:Itraconazole; D007654:Ketoconazole / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D009181:Mycoses / Q000188:drug therapy*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*
D000935:Antifungal Agents; D017964:Itraconazole; D015725:Fluconazole; D007654:Ketoconazole
Aktuelle Entwicklungen in der antimykotischen Therapie in Gynäkologie und Geburtshilfe.